- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1741-7015
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Urine metabolome profiling of immune-mediated inflammatory diseases ; volume:14 ; number:1 ; day:8 ; month:9 ; year:2016 ; pages:1-12 ; date:12.2016
BMC medicine ; 14, Heft 1 (8.9.2016), 1-12, 12.2016
- Beteiligte Personen und Organisationen
-
Alonso, Arnald
Julià, Antonio
Vinaixa, Maria
Domènech, Eugeni
Fernández-Nebro, Antonio
Cañete, Juan D.
Ferrándiz, Carlos
Tornero, Jesús
Gisbert, Javier P.
Nos, Pilar
Casbas, Ana Gutiérrez
Puig, Lluís
González-Álvaro, Isidoro
Pinto-Tasende, José A.
Blanco, Ricardo
Rodríguez, Miguel A.
Beltran, Antoni
Correig, Xavier
Marsal, Sara
SpringerLink (Online service)
- DOI
-
10.1186/s12916-016-0681-8
- URN
-
urn:nbn:de:1111-201703164761
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 10:47 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Alonso, Arnald
- Julià, Antonio
- Vinaixa, Maria
- Domènech, Eugeni
- Fernández-Nebro, Antonio
- Cañete, Juan D.
- Ferrándiz, Carlos
- Tornero, Jesús
- Gisbert, Javier P.
- Nos, Pilar
- Casbas, Ana Gutiérrez
- Puig, Lluís
- González-Álvaro, Isidoro
- Pinto-Tasende, José A.
- Blanco, Ricardo
- Rodríguez, Miguel A.
- Beltran, Antoni
- Correig, Xavier
- Marsal, Sara
- SpringerLink (Online service)
Ähnliche Objekte (12)
Cancer risk in immune-mediated inflammatory diseases (IMID)
IMID-Biobank: Biobank of immune-mediated inflammatory diseases (IMIDs)
CXCL13: a common target for immune-mediated inflammatory diseases
Immune monitoring and treatment in immune-mediated inflammatory diseases
Multidisciplinary Management of Spondyloarthritis-Related Immune-Mediated Inflammatory Disease
Review of Adalimumab Biosimilar SB5 in Immune-Mediated Inflammatory Diseases
Multivariate classification of urine metabolome profiles for breast cancer diagnosis
Plasma steroid metabolome profiling in patients with adrenal incidentalomas
The future of biosimilars: Maximizing benefits across immune-mediated inflammatory diseases
The Future of Biosimilars: Maximizing Benefits Across Immune-Mediated Inflammatory Diseases
COVID-19 vaccination of patients with chronic immune-mediated inflammatory disease
Plasma Metabolome Profiling Identifies Metabolic Subtypes of Pancreatic Ductal Adenocarcinoma
Cancer risk in immune-mediated inflammatory diseases (IMID)
IMID-Biobank: Biobank of immune-mediated inflammatory diseases (IMIDs)
CXCL13: a common target for immune-mediated inflammatory diseases
Immune monitoring and treatment in immune-mediated inflammatory diseases
Multidisciplinary Management of Spondyloarthritis-Related Immune-Mediated Inflammatory Disease
Review of Adalimumab Biosimilar SB5 in Immune-Mediated Inflammatory Diseases
Multivariate classification of urine metabolome profiles for breast cancer diagnosis
Plasma steroid metabolome profiling in patients with adrenal incidentalomas
The future of biosimilars: Maximizing benefits across immune-mediated inflammatory diseases
The Future of Biosimilars: Maximizing Benefits Across Immune-Mediated Inflammatory Diseases
COVID-19 vaccination of patients with chronic immune-mediated inflammatory disease
Plasma Metabolome Profiling Identifies Metabolic Subtypes of Pancreatic Ductal Adenocarcinoma
Cancer risk in immune-mediated inflammatory diseases (IMID)
IMID-Biobank: Biobank of immune-mediated inflammatory diseases (IMIDs)
CXCL13: a common target for immune-mediated inflammatory diseases
Immune monitoring and treatment in immune-mediated inflammatory diseases
Multidisciplinary Management of Spondyloarthritis-Related Immune-Mediated Inflammatory Disease
Review of Adalimumab Biosimilar SB5 in Immune-Mediated Inflammatory Diseases
Multivariate classification of urine metabolome profiles for breast cancer diagnosis
Plasma steroid metabolome profiling in patients with adrenal incidentalomas
The future of biosimilars: Maximizing benefits across immune-mediated inflammatory diseases
The Future of Biosimilars: Maximizing Benefits Across Immune-Mediated Inflammatory Diseases
COVID-19 vaccination of patients with chronic immune-mediated inflammatory disease